The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model
Authors
Keywords
-
Journal
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume 40, Issue 1, Pages 72-82
Publisher
Informa UK Limited
Online
2017-12-06
DOI
10.1080/08923973.2017.1407941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB/c mice-based experimental setting
- (2016) Fatemeh Fakhraee et al. ACTA TROPICA
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis
- (2012) Rajesh Ravindran et al. BMC MICROBIOLOGY
- The role of liposome–protamine–DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice
- (2012) Seyedeh Hoda Alavizadeh et al. EXPERIMENTAL PARASITOLOGY
- Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis
- (2012) Vahid Heravi Shargh et al. PARASITOLOGY RESEARCH
- Adjuvants for Leishmania vaccines: from models to clinical application
- (2012) Vanitha S. Raman et al. Frontiers in Immunology
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
- (2011) James J. Moon et al. NATURE MATERIALS
- The development and clinical evaluation of second-generation leishmaniasis vaccines
- (2011) Malcolm S. Duthie et al. VACCINE
- Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection
- (2011) Saumyabrata Mazumder et al. PLoS Neglected Tropical Diseases
- Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis
- (2009) Sassan Noazin et al. VACCINE
- Coencapsulation of CpG Oligodeoxynucleotides with Recombinant Leishmania major Stress-Inducible Protein 1 in Liposome Enhances Immune Response and Protection against Leishmaniasis in Immunized BALB/c Mice
- (2008) A. Badiee et al. Clinical and Vaccine Immunology
- gp63 in Stable Cationic Liposomes Confers Sustained Vaccine Immunity to Susceptible BALB/c Mice Infected with Leishmania donovani
- (2008) S. Bhowmick et al. INFECTION AND IMMUNITY
- Cationic liposomal lipids: From gene carriers to cell signaling
- (2008) Caroline Lonez et al. PROGRESS IN LIPID RESEARCH
- First generation leishmaniasis vaccines: A review of field efficacy trials
- (2008) Sassan Noazin et al. VACCINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started